44 related articles for article (PubMed ID: 17030353)
1. Salvage high intensity focused ultrasound for residual or recurrent cervical cancer after definitive chemoradiotherapy.
Zhong Q; Tang F; Ni T; Chen Y; Liu Y; Wu J; Zhou W; Feng Z; Lu X; Tan S; Zhang Y
Front Immunol; 2022; 13():995930. PubMed ID: 36325337
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of elderly women with uterin cervical cancer.
Birge Ö; Bakır MS; Karadag C; Doğan S; Tuncer HA; Simsek T
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1570. PubMed ID: 34632735
[TBL] [Abstract][Full Text] [Related]
3. Preoperative weight loss is associated with poorer prognosis in operable esophageal cancer patients: A single-center retrospective analysis of a large cohort of Chinese patients.
Zhang S; Tan Y; Cai X; Luo K; Wu Z; Lu J
J Cancer; 2020; 11(7):1994-1999. PubMed ID: 32194811
[No Abstract] [Full Text] [Related]
4. Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB.
Zhou J; Chen Y; Xu X; Yan D; Lou H
Medicine (Baltimore); 2018 Jan; 97(2):e9323. PubMed ID: 29480826
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study.
Liu YM; Ni LQ; Wang SS; Lv QL; Chen WJ; Ying SP
World J Surg Oncol; 2018 Jan; 16(1):18. PubMed ID: 29378625
[TBL] [Abstract][Full Text] [Related]
6. Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.
Shen S; Araujo JL; Altorki NK; Sonett JR; Rodriguez A; Sungur-Stasik K; Spinelli CF; Neugut AI; Abrams JA
Dis Esophagus; 2017 Sep; 30(9):1-7. PubMed ID: 28859366
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer.
Chen B; Liu L; Xu H; Yang Y; Zhang L; Zhang F
Exp Ther Med; 2015 Mar; 9(3):1063-1067. PubMed ID: 25667679
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of older patients with cervical cancer.
Gao Y; Ma JL; Gao F; Song LP
Clin Interv Aging; 2013; 8():783-8. PubMed ID: 23836968
[TBL] [Abstract][Full Text] [Related]
9. Nomogram prediction for overall survival of patients diagnosed with cervical cancer.
Polterauer S; Grimm C; Hofstetter G; Concin N; Natter C; Sturdza A; Pötter R; Marth C; Reinthaller A; Heinze G
Br J Cancer; 2012 Sep; 107(6):918-24. PubMed ID: 22871885
[TBL] [Abstract][Full Text] [Related]
10. The increasing frequency of cervical cancer in Korean women under 35.
Han CH; Cho HJ; Lee SJ; Bae JH; Bae SN; Namkoong SE; Park JS
Cancer Res Treat; 2008 Mar; 40(1):1-5. PubMed ID: 19688057
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for recurrent cervical cancer.
Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for recurrent cervical carcinoma.
Moore DH
Curr Opin Oncol; 2006 Sep; 18(5):516-9. PubMed ID: 16894302
[TBL] [Abstract][Full Text] [Related]
14. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
Kastritis E; Bamias A; Bozas G; Koutsoukou V; Voulgaris Z; Vlahos G; Rodolakis A; Gika D; Papadimitriou C; Dimopoulos MA
Gynecol Oncol; 2007 Feb; 104(2):372-6. PubMed ID: 17030353
[TBL] [Abstract][Full Text] [Related]
15. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
Kastritis E; Bamias A; Efstathiou E; Gika D; Bozas G; Zorzou P; Sarris K; Papadimitriou C; Dimopoulos MA
Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S
Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
